FY2025 · ended Mar 31, 2025 · Revenue $6.56M, -0.5% YoY · Filed Jul 10, 2025
Encision, Inc. (ECIA) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Mar 31, 2025, it reported revenue of $6.6 million and a net loss of $220,198. Free cash flow was -$109,363. As of Sep 30, 2025 it held $71,731 in cash and investments and $1.3 million in total debt.
Revenue (TTM)
$6.30M
-3.0% vs year-ago TTM
Net income (TTM)
$-380,942
+45.0% vs year-ago TTM
Operating cash flow (TTM)
$-489,796
-244.0% vs year-ago TTM
Free cash flow (TTM)
$-544,867
-290.8% vs year-ago TTM
EPS (TTM)
$-0.03
+47.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
11.88M
+0.0% vs prior year
Net cash
$-1.23M
as of Sep 30, 2025
Operating margin
-5.1%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ECIA (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- CO
- Headquarters
- Boulder, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 930775
- Former names
- ELECTROSCOPE INC (until Aug 1, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $6.6M | $6.6M | $7.3M | $7.7M | $7.5M |
| Operating income | -$171,980 | -$640,783 | -$302,797 | -$594,934 | -$61,641 |
| Net income | -$220,198 | -$691,783 | -$323,945 | -$65,594 | $584,734 |
| Diluted EPS | -$0.02 | -$0.06 | -$0.03 | — | — |
| Operating cash flow | -$54,948 | $144,389 | -$861,485 | -$444,432 | $219,946 |
| Free cash flow | -$109,363 | $132,339 | -$1.0M | -$461,982 | $189,926 |
| Total assets | $3.7M | $3.8M | $4.1M | $4.8M | $5.7M |
| Total liabilities | $2.0M | $2.0M | $1.6M | $2.0M | $2.9M |
| Stockholders' equity | $1.7M | $1.8M | $2.5M | $2.7M | $2.8M |
| Cash and investments | $257,433 | $42,509 | $188,966 | $949,645 | $1.5M |
| Total debt | $696,610 | $1.1M | $820,794 | $926,808 | $1.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2025 | Dec 8, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Shareholder vote results, Regulation FD disclosure
|
Aug 22, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 15, 2025 | Jun 30, 2025 |
All 745 Encision, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.